The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities

@article{Buja2020TheES,
  title={The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities},
  author={L. Buja and D. Wolf and Bihong Zhao and B. Akkanti and Michelle M McDonald and L. Lelenwa and N. Reilly and G. Ottaviani and M. Elghetany and D. Trujillo and G. Aisenberg and M. Madjid and B. Kar},
  journal={Cardiovascular Pathology},
  year={2020},
  volume={48},
  pages={107233 - 107233}
}
Abstract This paper collates the pathological findings from initial published autopsy reports on 23 patients with Coronavirus Disease 2019 (COVID-19) from 5 centers in the United States of America, including 3 cases from Houston, Texas. Findings confirm that COVID-19 is a systemic disease with major involvement of the lungs and heart. Acute COVID-19 pneumonia has features of a distinctive acute interstitial pneumonia with: a diffuse alveolar damage (DAD) component, coupled with… Expand
Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia
TLDR
The autopsy findings confirm that COVID-19 is a systemic disease, with major involvement of the lungs, that increases the risk of cardiac and vascular complications including acute myocardial injury and thrombotic/thromboembolic events. Expand
Fatal outcome of SARS-CoV-2 infection (B1.1.7) in a 4-year-old child
This case report highlights details of a case of critical acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) with B1.1.7 variant in a 4-year-old girl who died due to pneumonia and pulmonaryExpand
New Mexico's COVID-19 Experience.
TLDR
Full autopsy examination on the first 20 severe acute respiratory syndrome coronavirus 2-positive decedents revealed that some extent of diffuse alveolar damage in every death due to COVID-19 played some role. Expand
REVIEW OF CARDIOPULMONARY AUTOPSY FINDINGS IN DECEASED COVID-19 POSITIVE PATIENTS IN A TERTIARY CARE CENTER IN CENTRAL INDIA
TLDR
The present study aims to document the cardiopulmonary abnormalities found in autopsies of COVID-positive patients conducted at the institution while simultaneously conducting a review of the available international literature on the related topic. Expand
Pathophysiology and Cardiac Autopsy in COVID-19 related Myocarditis
TLDR
This infectious disease is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2) which emerged in Wuhan, China, in December 2019, and rapidly spread across the world. Expand
COVID-19: The Heart of the Matter—Pathological Changes and a Proposed Mechanism
  • S. Fox, R. Heide
  • Medicine
  • Journal of cardiovascular pharmacology and therapeutics
  • 2021
TLDR
The literature to date regarding the gross and microscopic findings of COVID-19 cardiac involvement is reviewed, the findings from over 40 cases from the authors' academic medical center are presented, and mechanisms by which patients develop small elevations in troponin are proposed. Expand
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
TLDR
In this small series, vascular angiogenesis distinguished the pulmonary pathobiology of Covid-19 from that of equally severe influenza virus infection. Expand
COVID-19: a Disease with a Potpourri of Histopathologic Findings—a Literature Review and Comparison to the Closely Related SARS and MERS
Since the coronavirus disease 2019 (COVID-19) pandemic has hit the entire world, there is ample knowledge regarding its clinical course and prognostic biomarkers. Still, the pathophysiology ofExpand
Histopathology features of the lung in COVID-19 patients
TLDR
COVID-19 is the infectious disease caused by the recently discovered coronavirus, SARS-CoV-2, unknown before the outbreak in Wuhan, China, in December 2019, and diffuse alveolar damage commonly described in all the postmortem series up to date is commonly described. Expand
Pulmonary pathology of COVID-19: a review of autopsy studies.
  • A. Borczuk
  • Medicine
  • Current opinion in pulmonary medicine
  • 2021
TLDR
The heterogeneity of fatal cases - persistence of viral infection in lung, clearance of virus but severe lung injury, thrombosis, and exaggerated immune response - suggest that antiviral, antithrombotic, anti-inflammatory, and supportive therapy play a role in treatment, but that the patient-specific cause and timing of the lung injury is important in choosing intervention. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 135 REFERENCES
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
TLDR
Pathologic examinations revealed that apart from the tumors, the lungs of both patients exhibited edema, proteinaceous exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular infiltration, and multinucleated giant cells, which likely represent an early phase of the lung pathology of COVID-19 pneumonia. Expand
Pulmonary pathology of severe acute respiratory syndrome in Toronto
TLDR
It is indicated that the lungs of patients who die of SARS are almost always positive for the SARS-associated coronavirus by RT-PCR, and may show features of both diffuse alveolar damage and acute fibrinous and organizing pneumonia patterns of acute injury. Expand
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Although the respiratory and immune systems are the major targets of Coronavirus Disease 2019 (COVID-19), acute kidney injury and proteinuria have also been observed. Currently, detailedExpand
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis☆
TLDR
An analysis of the current scientific literature is performed to investigate whether the measurement of cardiac troponin I (cTnI) or cardiac Troponin T ( cTnT) may help predict clinical severity in patients with COVID-19. Expand
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).
TLDR
This case report describes an otherwise healthy 53-year-old woman who tested positive for CO VID-19 and was admitted to the cardiac care unit in March 2020 for acute myopericarditis with systolic dysfunction, confirmed on cardiac magnetic resonance imaging, the week after onset of fever and dry cough due to COVID-19. Expand
Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections
TLDR
SARS-CoV-2 represents the third novel coronavirus to cause widespread human disease since 2002, and the primary pathology was diffuse alveolar damage with virus located in the pneumocytes, however, other major organs including the heart and kidneys may be susceptible to viral replication and damage leading to increased mortality in those with disseminated disease. Expand
Kidney disease is associated with in-hospital death of patients with COVID-19
TLDR
The findings show the prevalence of kidney disease on admission and the development of AKI during hospitalization in patients with COVID-19 is high and is associated with in-hospital mortality, and clinicians should increase their awareness of kidney patients with severe CO VID-19. Expand
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China
TLDR
The impact of the COVID-19 outbreak on STEMI care in Hong Kong is described through a handful of recent cases of patients with STEMI who underwent PPCI at a single center. Expand
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
TLDR
Diverse clinical manifestations and laboratory abnormalities occur in patients with cardiovascular injury in COVID-19, characterizing the development of this complication, as well as providing clues to diagnosis and treatment. Expand
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
TLDR
In this depictive study of 85 fatal cases of COVID-19, most cases were males aged over 50 years with noncommunicable chronic diseases, and the majority of the patients died of multiple organ failure. Expand
...
1
2
3
4
5
...